Newbridge Financial Services Group, Inc. Editas Medicine, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 300 shares of EDIT stock, worth $873. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 500
40.0%
Holding current value
$873
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EDIT
# of Institutions
243Shares Held
58.9MCall Options Held
494KPut Options Held
417K-
Vanguard Group Inc Valley Forge, PA8.03MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.78MShares$22.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$17.5 Million0.92% of portfolio
-
State Street Corp Boston, MA4.59MShares$13.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.46MShares$7.16 Million0.01% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $200M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...